PARP Inhibitors in Breast and Ovarian Cancer

SIMPLE SUMMARY: Targeted therapy has revolutionised oncological treatments in cancer with great efficacy and a more tolerable side effect profile as compared to standard chemotherapy. Poly (ADP-ribose) polymerase (PARP) inhibitors has demonstrated in their effective management of BRCA1/BRCA2 mutant...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Samuel S. Y., Jie, Yeo Ee, Cheng, Sim Wey, Ling, Goh Liuh, Ming, Heong Valerie Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137187/
https://www.ncbi.nlm.nih.gov/pubmed/37190285
http://dx.doi.org/10.3390/cancers15082357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137187/
https://www.ncbi.nlm.nih.gov/pubmed/37190285
http://dx.doi.org/10.3390/cancers15082357

Ejemplares similares